Session: Crystallization of Pharmaceutical and Biological Molecules II (2009 Annual Meeting)

Description:

This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:

Crystallization and Evaporation

Co-Sponsor(s):

Process Research and Innovation (12a)

Chair:

Daniel Jarmer
Sr. Research Scientist
Eli Lilly and Company
Chemical Product Research and Development
Indianapolis, IN 46285
Phone Number: 317-276-7594
Email: jarmerdj@lilly.com

Co-Chair:

Xing Wang

Papers:

303a

Effect of Freezing Rate and Geometry On Protein Frozen Storage Stability
Maria Andrea Miller, University of Texas at Austin; Miguel A. Rodrigues, University of Texas at Austin; Matt Glass, University of Texas at Austin; Jennifer Maynard, University of Texas at Austin; Keith P. Johnston, University of Texas at Austin; Satish Singh, Pfizer

303b

Effects of Solubilizers On Crystallization of Human Gamma D-Crystallin
Quinta Nwanosike, Georgia Institute of Technology; Athanassios Sambanis, Georgia Institute of Technology; Ronald W. Rousseau, Georgia Institute of Technology

303c

Development of a Large-Scale Crystallization Step for the Purification of a Recombinant Therapeutic Protein
Evan Shave, Genentech; Patricia Rancatore, Genentech; Bryan Bean, Genentech; Timothy Mathews, Genentech

303d

Microfluidic Platforms for in Meso Membrane Protein Crystallization
S.L. Perry, University of Illinois at Urbana-Champaign; D.S. Khvostichenko, University of Illinois at Urbana-Champaign; S. Guha, University of Illinois at Urbana-Champaign; G.W. Roberts, University of Illinois at Urbana-Champaign; C.F. Zukoski, University of Illinois at Urbana-Champaign; R.B. Gennis, University of Illinois at Urbana-Champaign; P.J.A. Kenis, University of Illinois at Urbana-Champaign

303e

Lecithin as An Antistatic Agent for Pure API Crystallizations in Organic Solvents
Ivan H. Lee, Merck & Co., Inc.

303f

Effects of Additives On the Crystallization of Calcium Salts
Marina Tsianou, University at Buffalo - The State University of New York

See more of this Group/Topical: Separations Division

<< Previous Session | Next Session >>